Amit Malhotra: The Expanding Role of Upadacitinib Across Autoimmune and Inflammatory Disorders
Amit Malhotra, Chairman of Headquarters Committee at IADVL, shared a post on LinkedIn:
“Had the privilege of attending a highly informative CME on Upadacitinib at Dehradun.
The scientific discussions highlighted how JAK-STAT inhibitors are transforming the management of several chronic inflammatory and autoimmune disorders.
Upadacitinib works by selectively inhibiting Janus Kinase (JAK) pathways, thereby blocking inflammatory signals transmitted through the JAK-STAT pathway.
This targeted mechanism helps reduce inflammation, itching, pain, and tissue damage while improving patient outcomes.
The molecule has demonstrated impressive efficacy in conditions such as Atopic Dermatitis, Alopecia Areata, Vitiligo, Psoriatic Arthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, and Ulcerative Colitis.
With rapid onset of action and sustained disease control, JAK inhibitors represent a significant advancement in precision medicine.
Grateful to the organizers and faculty for an enriching academic experience and valuable clinical insights.
Caution: Do not self medicate.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 15:23Bringing Hope and Treatment Access to Morocco’s Hemophilia Community – World Federation of Hemophilia
-
Sep 25, 2026, 15:22Alejandro González Veliz: Targeting Atherosclerosis Before the First Event
-
Sep 25, 2026, 15:00Sarah Richardson: Finding Strength Through Bleeding Disorders Advocacy
-
Sep 25, 2026, 14:54James Fildes: Modeling Device Related Thrombosis in Multi Organ Systems
-
Sep 25, 2026, 14:51Platelet Metabolic Reprogramming: How Cellular Energy Drives Thrombosis
-
Sep 25, 2026, 14:46Thomas Maxwell: From Hemophilia Shame to Strength – Walking for Bleeding Disorders
-
Sep 25, 2026, 14:35Sarita Rani Jaiswal: Sharing Basic Science Insights at EBMT HWP 2026
-
Sep 25, 2026, 14:12Managing Breakthrough Bleeds in Hemophilia – National Bleeding Disorders Foundation
-
Sep 25, 2026, 13:50Alejandro González Veliz: Beyond the Golden Hour in Stroke Care